PharmiWeb.com - Global Pharma News & Resources

General - Press Releases

Date Title Company
02-Nov-2022 Global Track and Trace Solutions Market Report 2022: Stringent Regulations and Standards for Serialization Driving Growth - ResearchAndMarkets.com Businesswire
02-Nov-2022 Renovion Announces First Patient Enrolled in Phase 2 Clinical Study Evaluating ARINA-1 for the Treatment of Non-CF Bronchiectasis Businesswire
02-Nov-2022 PathAI to Present Recent Advances in Applying AI-Powered Pathology Towards Liver Disease at the American Association for the Study of Liver Diseases (AASLD) 2022 Liver Meeting Businesswire
02-Nov-2022 Edwards Announces New Dry Pump Manufacturing Facility in Western New York Businesswire
02-Nov-2022 ClearSource High-Purity Alcohol Receives 2022 Technology Award Businesswire
02-Nov-2022 AbCellera’s First Program with Regeneron in Multi-Target Collaboration Advances in Preclinical Development Businesswire
02-Nov-2022 Insights on the Corporate Training Global Market to 2030 - Rising Concept of Micro-Learning is Boosting Growth - ResearchAndMarkets.com Businesswire
02-Nov-2022 Global Gastrointestinal Therapeutics Strategic Business Report 2022: Market to Reach $84.4 Billion by 2027 - Crohn's Disease is Expected to Account for $16.3 Billion - ResearchAndMarkets.com Businesswire
02-Nov-2022 Evolus to Participate in November Conferences Businesswire
02-Nov-2022 24-Month Data from Surmodics’ TRANSCEND Trial Presented at VIVA 2022 Conference Businesswire
02-Nov-2022 Applied Industrial Technologies Acquires Automation, Inc. Businesswire
02-Nov-2022 Simulations Plus and the University of Florida Awarded New FDA Contract to Support Development and Regulatory Assessment of Inhaled Products Businesswire
02-Nov-2022 OrsoBio Acquires Phase 2-Ready, Selective ACC2 Inhibitor from Shionogi & Co., Ltd. for the Treatment of Type 2 Diabetes Businesswire
02-Nov-2022 Kenco Group Launches Life Sciences Division Businesswire
02-Nov-2022 Concerto Biosciences Raises $23 Million in Series A to Advance Product Development, Expand Pipeline Businesswire
02-Nov-2022 Equillium Announces Initiation of Phase 1 study of EQ102, A First-in-Class Multi-Cytokine Inhibitor of IL-15 and IL-21 Targeting Celiac Disease Businesswire
02-Nov-2022 Stratasys Makes Strategic Investment in Axial3D Businesswire
02-Nov-2022 Bluestar Genomics Presents Positive Results From Validation Study in Pancreatic Cancer Detection at American Pancreatic Association (APA) Annual Meeting Businesswire
02-Nov-2022 Viz.ai Partners with Us2.ai to Deliver AI-Enabled Echocardiography Decision Support with the Viz™ Platform Businesswire
02-Nov-2022 Amneal Receives FDA Approval for Leuprolide Acetate Injection Businesswire